Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Blasi
Benedikt Blasi, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20120097240 | SOLAR CELL AND METHOD FOR THE PRODUCTION THEREOF - A solar cell, including a silicon substrate ( | 04-26-2012 |
Carlo Mario Di Blasi, Francofonte IT
| Patent application number | Description | Published |
|---|---|---|
| 20100066053 | Foldable frame for a vehicle with two or more wheels - Foldable frame for vehicles with two or more wheels characterized in that it comprises a front fork connected in a usual way to a steering column tube. Said steering column tube is, in turn, connected to a main frame of the vehicle by means of a hinge and by means of a connecting rod which can be operated to make the fork rotate about the hinge to position it adjacent to the frame and thus reduce the overall longitudinal size of the folded vehicle. | 03-18-2010 |
Carmelo Di Blasi, Francofonte IT
| Patent application number | Description | Published |
|---|---|---|
| 20100066053 | Foldable frame for a vehicle with two or more wheels - Foldable frame for vehicles with two or more wheels characterized in that it comprises a front fork connected in a usual way to a steering column tube. Said steering column tube is, in turn, connected to a main frame of the vehicle by means of a hinge and by means of a connecting rod which can be operated to make the fork rotate about the hinge to position it adjacent to the frame and thus reduce the overall longitudinal size of the folded vehicle. | 03-18-2010 |
Christopher L. Blasi, Flanders, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110258102 | Precious metal financial instrument - In accordance with the principles of the present invention, a computer-implemented precious metals investment product and process for pricing a precious metals composite product are provided. A measured unit of trade is established. The measured unit of trade comprises a plurality of precious metal components. The measured unit of trade is quoted and traded as a unit, thus allowing for uniformity in the ongoing offers to buy and sell a fixed quantity, or multiples of this fixed quantity, and pricing consistency for the metals. The precious metals components are backed by physical precious metals. The precious metals components are electronically tracked and priced in live market prices. Live pricing of the precious metals composite product is provided utilizing the live pricing of the precious metal components. An investor retains the option to take delivery of their precious metals or to liquidate by a plurality of methods. | 10-20-2011 |
Francesco Blasi, Segrate (milan) IT
| Patent application number | Description | Published |
|---|---|---|
| 20090202550 | MONOCLONAL ANTIBODIES AND IMMUNODETECTION ASSAY SPECIFIC FOR THE CHEMOTACTIC EPITOPE OF THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR - The present invention describes monoclonal antibodies specific for the chemotactic epitope of the uPAR. In particular, the invention comprises monoclonal antibodies against uPAR fragments specifically recognizing in whole or in part the chemotactic sequence of uPAR connecting domain 1 to domain 2. | 08-13-2009 |
Francesco Blasi, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110027285 | METHODS AND AGENTS MODULATING UPA/UPAR ACTIVITY - This invention herein disclosed relates to the anti-HIV action of uPAR-activators or activated uPAR molecules, the control of chemotaxis and cell migration by agents interfering with uPAR activation, a method for determining activated uPAR forms, the use of agents interfering with uPA/uPAR interaction for the diagnosis or therapy of diseases. | 02-03-2011 |
Francesco Blasi, Milan IT
| Patent application number | Description | Published |
|---|---|---|
| 20080280833 | Therapeutic Peptides Derived from Urokinase Plasminogen Activator Receptor - The present invention relates to a chemotactically active epitope derivable from the urokinase receptor, a mutated peptide that acts as an inhibitor of chemotaxis, and their therapeutic use. | 11-13-2008 |
Jane A. Blasi, South Danbury, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20120096708 | Electrolyte Additive for Non-Aqueous Electrochemical Cells - An electrochemical secondary cell is disclosed. The cell includes a cathode, an anode, a current collector including aluminum, and an electrolyte containing a perchlorate salt and a second salt. The electrolyte is essentially free of LiPF | 04-26-2012 |
Mélanie Blasi, Villenave D'Ornon FR
| Patent application number | Description | Published |
|---|---|---|
| 20100166930 | PROCESS FOR EXTRACTING CARBONYLATED COMPOUNDS FROM A DRINK BY LIQUID-SOLID EXTRACTION WITH A FUNCTIONALIZED INERT SUPPORT - The present invention relates to a process for extracting carbonylated compounds from a drink by liquid-solid extraction with a functionalized inert support containing nitrogenous nucleophilic functional groups. Advantageously, according to the present invention, the drink is wine or fruit juice. The process according to the present invention is advantageously applied to the reduction of the sulphur dioxide combination capacity of a drink such as wine. | 07-01-2010 |
Mélanie Blasi, Villenave D'Ornon FR
| Patent application number | Description | Published |
|---|---|---|
| 20100166930 | PROCESS FOR EXTRACTING CARBONYLATED COMPOUNDS FROM A DRINK BY LIQUID-SOLID EXTRACTION WITH A FUNCTIONALIZED INERT SUPPORT - The present invention relates to a process for extracting carbonylated compounds from a drink by liquid-solid extraction with a functionalized inert support containing nitrogenous nucleophilic functional groups. Advantageously, according to the present invention, the drink is wine or fruit juice. The process according to the present invention is advantageously applied to the reduction of the sulphur dioxide combination capacity of a drink such as wine. | 07-01-2010 |
Paolo Blasi, Belmonte Piceno IT
| Patent application number | Description | Published |
|---|---|---|
| 20090253754 | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine - A fast-dissolving film for use as a platform for the delivery of material to the oral cavity, comprising a film forming agent; a plasticizing agent; and a fast-dissolving, water-soluble agent; and methods for producing same. | 10-08-2009 |
Peter Blasi, Mahlberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100050525 | Revolving Door - A revolving door has two opposed concentric drum walls of a cylindrical segment shape. Door leaves are rotatably supported on a central axis. A floor and a ceiling are connected to the drum walls. Sensors monitor completely or partially at least one surface of an inner wall of the drum walls; the door leaves; the floor; and the ceiling with regard to whether an object is located on or at the at least one surface. | 03-04-2010 |
| 20100050530 | Sliding Door - A sliding door has a sliding leaf comprising a peripheral frame. A top guide rail and a bottom guide rail are provided, wherein the sliding leaf is slidable in the top and bottom guide rails. A drive motor is arranged within the frame of the sliding leaf either in the vertical area of the frame or in the horizontal area of the frame. | 03-04-2010 |
Udo Blasi, Hausleiten AT
| Patent application number | Description | Published |
|---|---|---|
| 20090117084 | BACTERIOPHAGE AND PROPHAGE PROTEINS IN CANCER GENE THERAPY - The present invention relates to the use of a polypeptide having a proliferation inhibitory activity or a cell death inducing activity on animal cells. The invention provides further means and methods to use said polypeptide and the corresponding nucleic acids sequence containing the coding regions of said polypeptide. The invention further relates to vectors expressing said polypeptide, to pharmaceutical compositions and therapeutic methods for treating proliferative disorders or diseases like cancer. Last but not least the invention provides a method for a gene therapeutic approach using said polypeptide having a proliferation inhibitory activity or a cell death inducing activity on animal cells. | 05-07-2009 |